ArticleHepatology communications2022

Statin use and risk of progression to liver cirrhosis in chronic hepatitis B independent of conventional risk factors: A nationwide study.

Byungyoon Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.